Offer new treatments only as part of post-market trials until data on meaningful outcomes are available, says Ben Goldacre to BMJ 4/15/2015 BMJ +
High-fructose sweeteners are a principal driver of type 2 diabetes 4/14/2015 Cleveland Clinic Diabetes Diet Endocrinology Mayo Clinic +